Literature DB >> 17196631

Neutralization of the haemorrhagic activities of viperine snake venoms and venom metalloproteinases using synthetic peptide inhibitors and chelators.

J-M Howes1, R D G Theakston, G D Laing.   

Abstract

Envenoming by the West African saw-scaled viper, Echis ocellatus resembles that of most vipers, in that it results in local blistering, necrosis and sometimes life-threatening systemic haemorrhage. While effective against systemic envenoming, current antivenoms have little or no effect against local tissue damage. The major mediators of local venom pathology are the zinc-dependant snake venom metalloproteinases (SVMPs). The high degree of structural and functional homology between SVMPs and their mammalian relatives the matrix metalloproteinases (MMPs) suggests that substrate/inhibitor interactions between these subfamilies are likely to be analogous. In this study, four recently developed MMP inhibitors (MMPIs) (Marimastat, AG-3340, CGS-270 23A and Bay-12 9566) are evaluated in addition to three metal ion chelators (EDTA, TPEN and BAPTA) for their ability to inhibit the haemorrhagic activities of the medically important E. ocellatus venom and one of its haemorrhagic SVMPs, EoVMP2. As expected, the metal ion chelators significantly inhibited the haemorrhagic activities of both whole E. ocellatus venom and EoVMP2, while the synthetic MMPIs show more variation in their efficacies. These variations suggest that individual MMPIs show specificity towards SVMPs and that their application to the neutralization of local haemorrhage may require a synthetic MMPI mixture, ensuring that a close structural component for each SVMP is represented.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17196631     DOI: 10.1016/j.toxicon.2006.11.020

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  22 in total

1.  Impaired autoproteolytic cleavage of mCLCA6, a murine integral membrane protein expressed in enterocytes, leads to cleavage at the plasma membrane instead of the endoplasmic reticulum.

Authors:  Melanie K Bothe; Lars Mundhenk; Carol L Beck; Matthias Kaup; Achim D Gruber
Journal:  Mol Cells       Date:  2012-02-15       Impact factor: 5.034

2.  Identification of new snake venom metalloproteinase inhibitors using compound screening and rational Peptide design.

Authors:  Fabián Villalta-Romero; Anna Gortat; Andrés E Herrera; Rebeca Arguedas; Javier Quesada; Robson Lopes de Melo; Juan J Calvete; Mavis Montero; Renato Murillo; Alexandra Rucavado; José María Gutiérrez; Enrique Pérez-Payá
Journal:  ACS Med Chem Lett       Date:  2012-06-14       Impact factor: 4.345

3.  Alleviation of viper venom induced platelet apoptosis by crocin (Crocus sativus): implications for thrombocytopenia in viper bites.

Authors:  M Sebastin Santhosh; R M Thushara; M Hemshekhar; K Sunitha; S Devaraja; K Kemparaju; K S Girish
Journal:  J Thromb Thrombolysis       Date:  2013-11       Impact factor: 2.300

4.  The murine goblet cell protein mCLCA3 is a zinc-dependent metalloprotease with autoproteolytic activity.

Authors:  Melanie K Bothe; Lars Mundhenk; Matthias Kaup; Christoph Weise; Achim D Gruber
Journal:  Mol Cells       Date:  2011-11-09       Impact factor: 5.034

5.  Crotalus atrox disintegrin reduces hemorrhagic transformation by attenuating matrix metalloproteinase-9 activity after middle cerebral artery occlusion in hyperglycemic male rats.

Authors:  Devin W McBride; Eric C K Gren; Wayne Kelln; William K Hayes; John H Zhang
Journal:  J Neurosci Res       Date:  2018-09-22       Impact factor: 4.164

6.  Novel apigenin based small molecule that targets snake venom metalloproteases.

Authors:  Venkatachalaiah Srinivasa; Mahalingam S Sundaram; Sebastian Anusha; Mahadevappa Hemshekhar; Siddaiah Chandra Nayaka; Kempaiah Kemparaju; Kesturu S Girish; Kanchugarakoppal S Rangappa
Journal:  PLoS One       Date:  2014-09-03       Impact factor: 3.240

7.  Crotalus atrox venom preconditioning increases plasma fibrinogen and reduces perioperative hemorrhage in a rat model of surgical brain injury.

Authors:  Cherine H Kim; Devin W McBride; Ronak Raval; Prativa Sherchan; Karen L Hay; Eric C K Gren; Wayne Kelln; Tim Lekic; William K Hayes; Brian S Bull; Richard Applegate; Jiping Tang; John H Zhang
Journal:  Sci Rep       Date:  2017-01-19       Impact factor: 4.379

8.  Preclinical validation of a repurposed metal chelator as an early-intervention therapeutic for hemotoxic snakebite.

Authors:  Laura-Oana Albulescu; Melissa S Hale; Stuart Ainsworth; Jaffer Alsolaiss; Edouard Crittenden; Juan J Calvete; Chloe Evans; Mark C Wilkinson; Robert A Harrison; Jeroen Kool; Nicholas R Casewell
Journal:  Sci Transl Med       Date:  2020-05-06       Impact factor: 17.956

9.  protective effect of tetracycline against dermal toxicity induced by Jellyfish venom.

Authors:  Changkeun Kang; Yeung Bae Jin; Jeongsoo Kwak; Hongseok Jung; Won Duk Yoon; Tae-Jin Yoon; Jong-Shu Kim; Euikyung Kim
Journal:  PLoS One       Date:  2013-03-11       Impact factor: 3.240

10.  Varespladib (LY315920) Appears to Be a Potent, Broad-Spectrum, Inhibitor of Snake Venom Phospholipase A2 and a Possible Pre-Referral Treatment for Envenomation.

Authors:  Matthew Lewin; Stephen Samuel; Janie Merkel; Philip Bickler
Journal:  Toxins (Basel)       Date:  2016-08-25       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.